Terms: = Breast cancer AND POLE, POLE1, 5426, FLJ21434, DKFZp434F222, ENSG00000177084 AND Prognosis
18 results:
1. SPC25 Functions as a Prognostic-Related Biomarker, and Its High Expression Correlates with Tumor Immune Infiltration and UCEC Progression.
Liao LX; Zhang M; Xu X; Zhang S; Guo YZ
Front Biosci (Landmark Ed); 2024 Feb; 29(2):69. PubMed ID: 38420826
[TBL] [Abstract] [Full Text] [Related]
2. Patterns of recurrence in surgically treated women for TP53-mutated endometrial carcinomas.
Pain FA; Beinse G; Azaïs H; Auvray-Kuentz M; Garcin LM; Delanoy N; Bentivegna E; Benoit L; Nguyen-Xuan HT; Blons H; Fabiano E; LE Frère Belda MA; Bats AS; Koual M
Eur J Surg Oncol; 2023 Sep; 49(9):106954. PubMed ID: 37349159
[TBL] [Abstract] [Full Text] [Related]
3. The prognosis of Skip Metastasis in Papillary Thyroid Microcarcinoma Is Better Than That of Continuous Metastasis.
Weng HY; Yan T; Qiu WW; Fan YB; Yang ZL
J Clin Endocrinol Metab; 2022 May; 107(6):1589-1598. PubMed ID: 35213704
[TBL] [Abstract] [Full Text] [Related]
4. Prognostic value of the TCGA molecular classification in uterine carcinosarcoma.
Travaglino A; Raffone A; Raimondo D; Arciuolo D; Angelico G; Valente M; Scaglione G; D'alessandris N; Casadio P; Inzani F; Mollo A; Santoro A; Seracchioli R; Franco Zannoni G
Int J Gynaecol Obstet; 2022 Jul; 158(1):13-20. PubMed ID: 34536971
[TBL] [Abstract] [Full Text] [Related]
5. pole, POLD1, and NTHL1: the last but not the least hereditary cancer-predisposing genes.
Magrin L; Fanale D; Brando C; Fiorino A; Corsini LR; Sciacchitano R; Filorizzo C; Dimino A; Russo A; Bazan V
Oncogene; 2021 Oct; 40(40):5893-5901. PubMed ID: 34363023
[TBL] [Abstract] [Full Text] [Related]
6. Molecular features of untreated breast cancer and initial metastatic event inform clinical decision-making and predict outcome: long-term results of ESOPE, a single-arm prospective multicenter study.
Callens C; Driouch K; Boulai A; Tariq Z; Comte A; Berger F; Belin L; Bièche I; Servois V; Legoix P; Bernard V; Baulande S; Chemlali W; Bidard FC; Fourchotte V; Salomon AV; Brain E; Lidereau R; Bachelot T; Saghatchian M; Campone M; Giacchetti S; Zafrani BS; Cottu P
Genome Med; 2021 Mar; 13(1):44. PubMed ID: 33722295
[TBL] [Abstract] [Full Text] [Related]
7. PEG3 mutation is associated with elevated tumor mutation burden and poor prognosis in breast cancer.
Zhang M; Zhang J
Biosci Rep; 2020 Aug; 40(8):. PubMed ID: 32729618
[TBL] [Abstract] [Full Text] [Related]
8. Mesonephric-like adenocarcinomas of the uterine corpus: report of a case series and review of the literature indicating poor prognosis for this subtype of endometrial adenocarcinoma.
Horn LC; Höhn AK; Krücken I; Stiller M; Obeck U; Brambs CE
J Cancer Res Clin Oncol; 2020 Apr; 146(4):971-983. PubMed ID: 31927619
[TBL] [Abstract] [Full Text] [Related]
9. Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer.
Liang X; Vacher S; Boulai A; Bernard V; Baulande S; Bohec M; Bièche I; Lerebours F; Callens C
Breast Cancer Res; 2018 Aug; 20(1):88. PubMed ID: 30086764
[TBL] [Abstract] [Full Text] [Related]
10. Solid papillary carcinoma with reverse polarity of the breast harbors specific morphologic, immunohistochemical and molecular profile in comparison with other benign or malignant papillary lesions of the breast: a comparative study of 9 additional cases.
Alsadoun N; MacGrogan G; Truntzer C; Lacroix-Triki M; Bedgedjian I; Koeb MH; El Alam E; Medioni D; Parent M; Wuithier P; Robert I; Boidot R; Arnould L
Mod Pathol; 2018 Sep; 31(9):1367-1380. PubMed ID: 29785016
[TBL] [Abstract] [Full Text] [Related]
11. [Histological and molecular classification of endometrial carcinoma and therapeutical implications].
Genestie C; Leary A; Devouassoux M; Auguste A
Bull Cancer; 2017 Dec; 104(12):1001-1012. PubMed ID: 29031505
[TBL] [Abstract] [Full Text] [Related]
12. RNA Sequencing Analysis Reveals Interactions between breast cancer or Melanoma Cells and the Tissue Microenvironment during Brain Metastasis.
Sato R; Nakano T; Hosonaga M; Sampetrean O; Harigai R; Sasaki T; Koya I; Okano H; Kudoh J; Saya H; Arima Y
Biomed Res Int; 2017; 2017():8032910. PubMed ID: 28210624
[TBL] [Abstract] [Full Text] [Related]
13. Fine needle aspiration cytology of neuroendocrine carcinoma of the breast--a case report and review of literature.
Kadir AA; Iyengar KR; Peh SC; Yip CH
Malays J Pathol; 2008 Jun; 30(1):57-61. PubMed ID: 19108413
[TBL] [Abstract] [Full Text] [Related]
14. [MUC1 (EMA): A key molecule of carcinogenesis?].
Leroy X; Buisine MP; Leteurtre E; Aubert S; Buob D; Porchet N; Copin MC
Ann Pathol; 2006 Sep; 26(4):257-66. PubMed ID: 17128152
[TBL] [Abstract] [Full Text] [Related]
15. Clinical features of choroidal metastases from carcinoid tumour.
She H; Zheng Y; Wang X; Quan Y; Sun N
Yan Ke Xue Bao; 2004 Mar; 20(1):15-8. PubMed ID: 15124527
[TBL] [Abstract] [Full Text] [Related]
16. p100: a novel proliferation-associated nuclear protein specifically restricted to cell cycle phases S, G2, and M.
Heidebrecht HJ; Buck F; Steinmann J; Sprenger R; Wacker HH; Parwaresch R
Blood; 1997 Jul; 90(1):226-33. PubMed ID: 9207457
[TBL] [Abstract] [Full Text] [Related]
17. [Eye involvement in cancer].
Vogel M
Klin Monbl Augenheilkd; 1997 Apr; 210(4):aA9-13. PubMed ID: 9235390
[TBL] [Abstract] [Full Text] [Related]
18. gamma-Glutamyltranspeptidase activity in human breast lesions: an unfavourable prognostic sign.
Bard S; Noël P; Chauvin F; Quash G
Br J Cancer; 1986 May; 53(5):637-42. PubMed ID: 2872909
[TBL] [Abstract] [Full Text] [Related]
